Search Results - "GOLDMACHER, Victor S"
-
1
SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies
Published in Clinical cancer research (01-09-2014)“…The CD38 cell surface antigen is expressed in diverse hematologic malignancies including multiple myeloma, B-cell non-Hodgkin lymphoma (NHL), B-cell chronic…”
Get full text
Journal Article -
2
A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells
Published in Blood advances (24-04-2018)“…The outlook for patients with refractory/relapsed acute myeloid leukemia (AML) remains poor, with conventional chemotherapeutic treatments often associated…”
Get full text
Journal Article -
3
Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates
Published in Journal of medicinal chemistry (26-05-2011)“…The synthesis and biological evaluation of hydrophilic heterobifunctional cross-linkers for conjugation of antibodies with highly cytotoxic agents are…”
Get full text
Journal Article -
4
Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
Published in Cancer research (Chicago, Ill.) (15-03-2010)“…Conjugation of cytotoxic compounds to antibodies that bind to cancer-specific antigens makes these drugs selective in killing cancer cells. However, many of…”
Get full text
Journal Article -
5
Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing
Published in Cancer research (Chicago, Ill.) (15-04-2006)“…Antibody-drug conjugates are targeted anticancer agents consisting of a cytotoxic drug covalently linked to a monoclonal antibody for tumor antigen-specific…”
Get full text
Journal Article -
6
High-affinity accumulation of a maytansinoid in cells via weak tubulin interaction
Published in PloS one (11-02-2015)“…The microtubule-targeting maytansinoids accumulate in cells and induce mitotic arrest at 250- to 1000-fold lower concentrations than those required for their…”
Get full text
Journal Article -
7
The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets
Published in EMBO molecular medicine (01-01-2013)“…There are considerable differences in tumour biology between adult and paediatric cancers. The existence of cancer initiating cells/cancer stem cells (CIC/CSC)…”
Get full text
Journal Article -
8
Cytomegalovirus Cell Death Suppressor vMIA Blocks Bax- but Not Bak-Mediated Apoptosis by Binding and Sequestering Bax at Mitochondria
Published in Proceedings of the National Academy of Sciences - PNAS (25-05-2004)“…We report that the cytomegalovirus-encoded cell death suppressor vMIA binds Bax and prevents Bax-mediated mitochondrial membrane permeabilization by…”
Get full text
Journal Article -
9
murine cytomegalovirus cell death suppressor m38.5 binds Bax and blocks Bax-mediated mitochondrial outer membrane permeabilization
Published in Apoptosis (London) (01-09-2008)“…Apoptosis is increasingly implicated as an early line of defense against viral infections. Viruses have devised numerous strategies to delay apoptosis of…”
Get full text
Journal Article -
10
Cytopathic Effects of the Cytomegalovirus-Encoded Apoptosis Inhibitory Protein vMIA
Published in Cell biology international (25-09-2006)“…Replication of human cytomegalovirus (CMV) requires the expression of the viral mitochondria-localized inhibitor of apoptosis (vMIA). vMIA inhibits apoptosis…”
Get full text
Journal Article -
11
A clinically relevant SCID-hu in vivo model of human multiple myeloma
Published in Blood (15-07-2005)“…We developed a novel in vivo multiple myeloma (MM) model by engrafting the interleukin 6 (IL-6)-dependent human MM cell line INA-6 into severe combined…”
Get full text
Journal Article -
12
A Cytomegalovirus-Encoded Mitochondria-Localized Inhibitor of Apoptosis Structurally Unrelated to Bcl-2
Published in Proceedings of the National Academy of Sciences - PNAS (26-10-1999)“…Human cytomegalovirus (CMV), a herpesvirus that causes congenital disease and opportunistic infections in immunocompromised individuals, encodes functions that…”
Get full text
Journal Article -
13
Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138+ multiple myeloma cells
Published in Blood (01-12-2004)“…We tested the in vitro and in vivo antitumor activity of the maytansinoid DM1 (N2′-deacetyl-N2′-(3-mercapto-1-oxopropyl)-maytansine), a potent antimicrotubule…”
Get full text
Journal Article -
14
Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses
Published in Virology (New York, N.Y.) (25-11-2003)“…Human cytomegalovirus (CMV) genes UL36 and UL37 encode viral inhibitor of caspase-8-induced apoptosis (vICA) and viral mitochondria inhibitor of apoptosis…”
Get full text
Journal Article -
15
An Anti-apoptotic Viral Protein That Recruits Bax to Mitochondria
Published in The Journal of biological chemistry (21-05-2004)“…The viral mitochondria-localized inhibitor of apoptosis (vMIA), encoded by the UL37 gene of human cytomegalovirus, inhibits apoptosis-associated mitochondrial…”
Get full text
Journal Article -
16
IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors
Published in Molecular cancer therapeutics (01-07-2015)“…A majority of ovarian and non-small cell lung adenocarcinoma cancers overexpress folate receptor α (FRα). Here, we report the development of an anti-FRα…”
Get full text
Journal Article -
17
Cell killing by antibody–drug conjugates
Published in Cancer letters (08-10-2007)“…Abstract Antibody–drug conjugates (ADCs) are designed to specifically bind to and kill cells expressing their target antigens. In addition to the obvious…”
Get full text
Journal Article -
18
Processing of Human Cytomegalovirus UL37 Mutant Glycoproteins in the Endoplasmic Reticulum Lumen prior to Mitochondrial Importation
Published in Journal of Virology (01-07-2006)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
19
Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication
Published in Antibody therapeutics (29-10-2024)“…Abstract Bispecific apoptosis triggers (BATs) are innovative bispecific antibodies designed to simultaneously target both a tumor-associated antigen and a…”
Get full text
Journal Article -
20
Statistics of the Distribution of the Abundance of Molecules with Various Drug Loads in Maytansinoid Antibody–Drug Conjugates
Published in Molecular pharmaceutics (01-06-2015)“…The maytansinoid antibody–drug conjugates (ADCs) in clinical development for cancer therapy each contain a derivative of the microtubule-targeting agent,…”
Get full text
Journal Article